Management tracks: Vivus, Peregrine

Cardiovascular, metabolic and pulmonary company Vivus Inc. (NASDAQ:VVUS) said CEO Seth Fischer will step down. Thomas King, a director, will serve as interim CEO as the company seeks a permanent replacement. King was president and CEO of Alexza Pharmaceuticals Inc. until its 2016 acquisition by Grupo Ferrer Internacional S.A. (Barcelona, Spain).

Biologics manufacturing company Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) said President and CEO Steven King has resigned. He is succeeded by Roger Lias, who is president of Peregrine’s contract development and manufacturing subsidiary Avid Bioservices Inc...